Inmune Bio Inc.

Inmune Bio Inc. is a clinical-stage biotechnology company focused on developing therapies that harness the power of the innate immune system to treat diseases. The company is dedicated to pioneering novel approaches for chronic inflammation and cancer. Inmune Bio's research centers around targeting the root causes of disease by modulating the innate immune response, aiming to restore immune balance and improve patient outcomes. Their pipeline includes therapies designed to address significant unmet medical needs in areas such as neuroinflammation and cancer progression. By leveraging its expertise in innate immunology, Inmune Bio seeks to create innovative treatments that offer transformative benefits for patients facing debilitating conditions. The company's commitment to scientific rigor and patient-centric drug development drives its pursuit of groundbreaking therapeutic solutions.